386 related articles for article (PubMed ID: 8030221)
1. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
[TBL] [Abstract][Full Text] [Related]
2. Functional modules important for activated expression of early genes of herpes simplex virus type 1 are clustered upstream of the TATA box.
Pande NT; Petroski MD; Wagner EK
Virology; 1998 Jun; 246(1):145-57. PubMed ID: 9657002
[TBL] [Abstract][Full Text] [Related]
3. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
[TBL] [Abstract][Full Text] [Related]
4. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
5. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
Lieu PT; Wagner EK
Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
[TBL] [Abstract][Full Text] [Related]
6. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
7. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
8. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
Hilton MJ; Mounghane D; McLean T; Contractor NV; O'Neil J; Carpenter K; Bachenheimer SL
Virology; 1995 Nov; 213(2):624-38. PubMed ID: 7491786
[TBL] [Abstract][Full Text] [Related]
9. Characterization of regulatory functions of the HSV-1 immediate-early protein ICP22.
Prod'hon C; Machuca I; Berthomme H; Epstein A; Jacquemont B
Virology; 1996 Dec; 226(2):393-402. PubMed ID: 8955059
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the initiator and downstream promoter elements of herpes simplex virus 1 late genes.
Woerner AM; Weir JP
Virology; 1998 Sep; 249(2):219-30. PubMed ID: 9791014
[TBL] [Abstract][Full Text] [Related]
11. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
Lee LY; Schaffer PA
J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
[TBL] [Abstract][Full Text] [Related]
12. A dominant mutant form of the herpes simplex virus ICP8 protein decreases viral late gene transcription.
Chen YM; Knipe DM
Virology; 1996 Jul; 221(2):281-90. PubMed ID: 8661438
[TBL] [Abstract][Full Text] [Related]
13. Upstream stimulatory factor family binds to the herpes simplex virus type 1 latency-associated transcript promoter.
Kenny JJ; Millhouse S; Wotring M; Wigdahl B
Virology; 1997 Apr; 230(2):381-91. PubMed ID: 9143295
[TBL] [Abstract][Full Text] [Related]
14. The equine herpesvirus type 1 immediate-early gene product contains an acidic transcriptional activation domain.
Smith RH; Zhao Y; O'Callaghan DJ
Virology; 1994 Aug; 202(2):760-70. PubMed ID: 8030239
[TBL] [Abstract][Full Text] [Related]
15. An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.
Griffith C; Noonan S; Lou E; Shillitoe EJ
Cancer Gene Ther; 2007 Dec; 14(12):985-93. PubMed ID: 17853922
[TBL] [Abstract][Full Text] [Related]
16. Role of anisomorphic DNA conformations in the negative regulation of a herpes simplex virus type 1 promoter.
Sarisky RT; Weber PC
Virology; 1994 Nov; 204(2):569-79. PubMed ID: 7941324
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter.
Gu B; Rivera-Gonzalez R; Smith CA; DeLuca NA
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9528-32. PubMed ID: 8415735
[TBL] [Abstract][Full Text] [Related]
18. Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4.
Zabierowski S; DeLuca NA
J Virol; 2004 Jun; 78(12):6162-70. PubMed ID: 15163709
[TBL] [Abstract][Full Text] [Related]
19. High efficiency transient expression of eukaryotic genes: use of an HSV-1 immediate early promoter (ICP4).
Liu X; Giza CC; Vrana KE
Biotechniques; 1990 Aug; 9(2):168-73. PubMed ID: 2169263
[TBL] [Abstract][Full Text] [Related]
20. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
